Targeting the EWS–FLI1 transcription factor in Ewing sarcoma

被引：0
|
作者：
R. Tancredi
A. Zambelli
G. A. DaPrada
V. Fregoni
L. Pavesi
A. Riccardi
S. Burdach
P. J. Grohar
M. D’Incalci
机构：
[1] I.R.C.C.S. Salvatore Maugeri Foundation,Medical Oncology Unit
[2] Piazza OMS - Organizzazione Mondiale della Sanità,Medical Oncology Unit, Azienda Ospedaliera Giovanni XXIII
[3] 1,Medical Oncology Unit, Department of Internal Medicine
[4] University of Pavia,Department of Pediatrics and Children’s Cancer Research Center (CCRC)
[5] Technische Universität München (TUM),Laboratory of Cancer Pharmacology, Department of Oncology
[6] Monroe Carrell Jr. Children’s Hospital and the Vanderbilt Ingram Cancer Center,undefined
[7] IRCCS-Istituto di Ricerche Farmacologiche Mario Negri,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Ewing sarcoma; Trabectedin; Irinotecan; Combination therapy; Transcription mechanism; Werner gene; EWS–FLI1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1317 / 1320
页数：3
相关论文
共 50 条
  • [1] Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
    Jacques, Camille
    Lamoureux, Francois
    Baud'huin, Marc
    Calleja, Lidia Rodriguez
    Quillard, Thibaut
    Amiaud, Jerome
    Tirode, Franck
    Redini, Francoise
    Bradner, James E.
    Heymann, Dominique
    Ory, Benjamin
    ONCOTARGET, 2016, 7 (17) : 24125 - 24140
  • [2] Targeting the EWS-FLI1 transcription factor in Ewing sarcoma
    Tancredi, R.
    Zambelli, A.
    DaPrada, G. A.
    Fregoni, V.
    Pavesi, L.
    Riccardi, A.
    Burdach, S.
    Grohar, P. J.
    D'Incalci, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1317 - 1320
  • [3] Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy
    Mancarella, Caterina
    Scotlandi, Katia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (31)
  • [4] Downstream EWS/FLI1 - upstream Ewing's sarcoma
    Heinrich Kovar
    Genome Medicine, 2
  • [5] EWS/FLI1 target genes and therapeutic opportunities in Ewing sarcoma
    Cidre-Aranaz, Florencia
    Alonso, Javier
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [6] Targeting the oncogenic transcription factor EWS-Fli1 by BET bromodomain inhibition in Ewing sarcoma
    Jacques, Camille
    Lamoureux, Francois
    Baud'huin, Marc
    Rodriguez-Calleja, Lidia
    Quillard, Thibaut
    Perrot, Pierre
    Tirode, Franck
    Redini, Francoise
    Bradner, James E.
    Heymann, Dominique
    Ory, Benjamin
    CANCER RESEARCH, 2016, 76
  • [7] Identification of mithramycin analogs with improved targeting of the EWS/FLI1 transcription factor
    Osgood, Christy
    Maloney, Nichole
    Kidd, Christopher G.
    Gebregiorgis, Meti
    Nunez, Luz E.
    Gonzalez-Sabin, Javier
    Helman, Lee J.
    Moris, Francisco
    Grohar, Patrick J.
    CANCER RESEARCH, 2015, 75
  • [8] USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma
    Mallard, Halle J.
    Wan, Shibiao
    Nidhi, Prakriti
    Hanscom-Trofy, Yvan D.
    Mohapatra, Bhopal
    Woods, Nicholas T.
    Lopez-Guerrero, Jose Antonio
    Llombart-Bosch, Antonio
    Machado, Isidro
    Scotlandi, Katia
    Kreiling, Natasha F.
    Perry, Megan C.
    Mirza, Sameer
    Coulter, Donald W.
    Band, Vimla
    Band, Hamid
    Ghosal, Gargi
    MOLECULAR CANCER RESEARCH, 2023, 21 (11) : 1186 - 1204
  • [9] EWS/FLI1 Hijacks UHRF1 to Drive the Malignancy of Ewing Sarcoma
    Xue, B.
    Feng, P.
    Shang, G.
    Xing, J.
    Li, X.
    Li, L.
    Zhao, J.
    Gong, H.
    Guan, H.
    Gassmann, H.
    Schober, S.
    Thiel, U.
    Burdach, S.
    Li, Y.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S146 - S147
  • [10] Efficacy of siRNA Nanocapsules Targeted Against the EWS–Fli1 Oncogene in Ewing Sarcoma
    Nedjma Toub
    Jean-Rémi Bertrand
    Ali Tamaddon
    Hind Elhamess
    Hervé Hillaireau
    Andrei Maksimenko
    Jean Maccario
    Claude Malvy
    Elias Fattal
    Patrick Couvreur
    Pharmaceutical Research, 2006, 23 : 892 - 900
12345